Scott M. Wasserman
Private Equity Investor bij Frazier Management LLC
Profiel
Scott M.
Wasserman is a Venture Partner at Frazier Management LLC since 2023.
Prior to this, he was the Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023 and Vice President & Global Development at Amgen, Inc. from 2015 to 2019.
Wasserman received his undergraduate degree from Haverford College in 1992, his graduate degree from Harvard Medical School in 1997, and his undergraduate degree from Stanford University School of Medicine in 2004.
Actieve functies van Scott M. Wasserman
Bedrijven | Functie | Begin |
---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01-10-2023 |
Eerdere bekende functies van Scott M. Wasserman
Bedrijven | Functie | Einde |
---|---|---|
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Algemeen Directeur | 01-06-2023 |
AMGEN INC. | Private Equity Investor | 01-05-2019 |
Opleiding van Scott M. Wasserman
Haverford College | Undergraduate Degree |
Harvard Medical School | Graduate Degree |
Stanford University School of Medicine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |